{"DataElement":{"publicId":"64678","version":"3","preferredName":"Metaplastic Carcinoma Mesenchymal Subtype Biphasic Type","preferredDefinition":"if metaplastic carcinoma is present, the biphasic mesenchymal element.","longName":"MET_CA_MES_SUB_BIP_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2191786","version":"1","preferredName":"Metaplastic Carcinoma Mesenchymal Subtype","preferredDefinition":"information related to metaplastic mesenchymal carcinoma subtype.","longName":"METPS_CA_MESCY_SUBTP","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206784","version":"1","preferredName":"Metaplastic Carcinoma","preferredDefinition":"Pertaining to or characterized by metaplasia.:A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","longName":"C25566:C2916","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metaplastic","conceptCode":"C25566","definition":"Pertaining to or characterized by metaplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0458-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207641","version":"1","preferredName":"Mesenchyme Subtype","preferredDefinition":"Embryonic tissue of mesodermal origin.  Develops into connective tissue, blood vessels, and lymphatic tissue.:Subtype; a group forming a type within a larger type.","longName":"C13301:C25696","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesenchyme","conceptCode":"C13301","definition":"Embryonic tissue of mesodermal origin.  Develops into connective tissue, blood vessels, and lymphatic tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2AF3-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E89F73EC-1459-5DD2-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance; set to Draft Mod status for Committee Review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2019138","version":"1","preferredName":"Metaplastic Carcinoma Mesenchymal Subtype Biphasic Type","preferredDefinition":"the histologic subtype of a mesenchymal metaplastic carcinoma or cancer tissue.","longName":"MET_CA_MES_SUB_B_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Epithelial","valueDescription":"EPITHELIAL","ValueMeaning":{"publicId":"2558727","version":"1","preferredName":"EPITHELIAL","longName":"2558727","preferredDefinition":"EPITHELIAL","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial","conceptCode":"C13315","definition":"A term that refers to the cells that make up the epithelial tissues.  They are found in the skin, and in the parenchyma, surface and lumen of internal organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B274-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A35D0A-5E3C-0FB3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Mesenchymal","valueDescription":"MESENCHYMAL","ValueMeaning":{"publicId":"2559174","version":"1","preferredName":"MESENCHYMAL","longName":"2559174","preferredDefinition":"MESENCHYMAL","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesenchymal","conceptCode":"C25721","definition":"Refers to cells that develop into connective tissue, blood vessels, and lymphatic tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B433-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A35D0A-5E3F-0FB3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Not specified","valueDescription":"Not specified","ValueMeaning":{"publicId":"2567693","version":"1","preferredName":"Not specified","longName":"2567693","preferredDefinition":"Not stated explicitly or in detail.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unspecified","conceptCode":"C38046","definition":"Not stated explicitly or in detail.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D57A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"LUY","dateModified":"2015-02-03","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2A35D0A-5E42-0FB3-E034-0003BA12F5E7","beginDate":"2003-12-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-27","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2207972","version":"1","preferredName":"Biphasic Type","preferredDefinition":"Biphasic; having two phases.:Type; a subdivision of a particular kind of thing.","longName":"C25435:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biphasic","conceptCode":"C25435","definition":"Occurring in or characterized by two stages or phases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-371C-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C3876A1D-3E0C-61A7-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-07-28","modifiedBy":"SHIDED","dateModified":"2013-07-05","changeDescription":"updated for ISO compliance; set to Draft Mod status for Committee Review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Biphasic Subtype","type":"Preferred Question Text","description":"Biphasic Subtype","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Biphasic Subtype, Metaplastic Carcinoma","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C3875927-7D17-619F-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2006-07-13","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-07-28","modifiedBy":"SHIDED","dateModified":"2013-07-05","changeDescription":"updated for ISO compliance; set to Draft Mod status for Committee Review; not fully finished by Path Committee previously, Non-core item - review to determine utility or retire","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}